Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study.

Jacob Edvinsson; Karin Warfvinge; Lars Edvinsson

doi:10.1186/s10194-015-0555-z

Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study.

Jacob Edvinsson, Karin Warfvinge, Lars Edvinsson

Medicine/Emergency Medicine, Lund

Research output: Contribution to journal › Article › peer-review

197 Downloads (Pure)

Abstract

Onabotulinumtoxin type A (BoNT-A) has been found to reduce pain in chronic migraine. The aim of the present study was to ask if BoNT-A can interact directly on sensory mechanisms in the trigeminal ganglion (TG) using an organ culture method.

Original language	English
Article number	73
Journal	Journal of Headache and Pain
Volume	16
DOIs	https://doi.org/10.1186/s10194-015-0555-z
Publication status	Published - 2015

Subject classification (UKÄ)

Neurology

Access to Document

10.1186/s10194-015-0555-z

SpringerOpen_Edvinsson_et_al

http://www.ncbi.nlm.nih.gov/pubmed/26245187?dopt=Abstract

Cite this

@article{4038bc4a22944921924c10e1756097a3,

title = "Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study.",

abstract = "Onabotulinumtoxin type A (BoNT-A) has been found to reduce pain in chronic migraine. The aim of the present study was to ask if BoNT-A can interact directly on sensory mechanisms in the trigeminal ganglion (TG) using an organ culture method.",

author = "Jacob Edvinsson and Karin Warfvinge and Lars Edvinsson",

year = "2015",

doi = "10.1186/s10194-015-0555-z",

language = "English",

volume = "16",

journal = "Journal of Headache and Pain",

issn = "1129-2369",

publisher = "Springer-Verlag Italia s.r.l.",

}

TY - JOUR

T1 - Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study.

AU - Edvinsson, Jacob

AU - Warfvinge, Karin

AU - Edvinsson, Lars

PY - 2015

Y1 - 2015

N2 - Onabotulinumtoxin type A (BoNT-A) has been found to reduce pain in chronic migraine. The aim of the present study was to ask if BoNT-A can interact directly on sensory mechanisms in the trigeminal ganglion (TG) using an organ culture method.

AB - Onabotulinumtoxin type A (BoNT-A) has been found to reduce pain in chronic migraine. The aim of the present study was to ask if BoNT-A can interact directly on sensory mechanisms in the trigeminal ganglion (TG) using an organ culture method.

U2 - 10.1186/s10194-015-0555-z

DO - 10.1186/s10194-015-0555-z

M3 - Article

C2 - 26245187

SN - 1129-2369

VL - 16

JO - Journal of Headache and Pain

JF - Journal of Headache and Pain

M1 - 73

ER -

Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this